Source: Eur Respir J 2012; 39: 156-162
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Menéndez R., Torres A., Reyes S., Zalacain R., Capelastegui A., Aspa J., Borderías L., Martín-Villasclaras J.J., Bello S., Alfageme I., de Castro F.R., Rello J., Molinos L., Ruiz-Manzano J.. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J 2012; 39: 156-162

Member's Comments

No comment yet.

Related content which might interest you: Duration of length of stay in pneumonia: influence of clinical factors and hospital type Source: Eur Respir J 2003 Oct 01;22(4):643-648 Year: 2003 Outcomes in females hospitalised with community-acquired pneumonia are worse than in males Source: Eur Respir J 2013; 41: 1135-1140 Year: 2013 Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment Source: Eur Respir J 2008; 32: 139-146 Year: 2008 Determinants of hospital costs in community-acquired pneumonia Source: Eur Respir J 2008; 31: 1061-1067 Year: 2008 Risk factors, etiology, and clinical outcomes of ventilator-associated pneumonia Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005 Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor Source: Eur Respir J 2004; 24 : 779-785 Year: 2004 Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Initial risk class and length of hospital stay in community-acquired pneumonia Source: Eur Respir J 2001; 18: 151-156 Year: 2001 A population-based study of the costs of care for community-acquired pneumonia Source: Eur Respir J 2004; 23: 610-616 Year: 2004 On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Community-acquired pneumonia (CAP) in the elderly: Prediction of mortality by physical symptoms, laboratory values and radiographic features on admission Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009